DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo


25.69 0.56 (2.23%)

Quote as of

company name or ticker

Recent Quotes

INSM $25.69 2.23%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $25.07
Previous Close $25.13
Daily Range $24.62 - $25.72
52-Week Range $12.17 - $28.66
Market Cap $1.6B
P/E Ratio -13.30
Dividend (Yield) $0.00 (0.0%)
Volume 408,974
Average Daily Volume 422,325
Current FY EPS -$1.94




Drug Makers

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website:

News & Commentary Rss Feed

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Insmed's (INSM) CEO Will Lewis on Q2 2015 Results - Earnings Call Transcript

Insmed (INSM) Q2 2015 Results - Earnings Call Webcast

Stocks Hitting 52-Week Highs

Use Options For a Chance To Buy INSM at a 62% Discount

Use Options For a Chance To Buy INSM at a 55% Discount

Morning Market Losers

Benzinga's Top #PreMarket Losers

Books-A-Million, HomeAway, Vaalco Energy Lead Monday's After-Hours Movers

Should You Buy Insmed Incorporated Ahead of Earnings? - Tale of the Tape

Use Options For a Chance To Buy INSM at a 52% Discount

See More INSM News...

INSM's Top Competitors

INSM $25.69 (2.23%)
Current stock: INSM
AMGN $155.89 (0.11%)
Current stock: AMGN
GILD $107.78 (-0.19%)
Current stock: GILD
BIIB $303.69 (-0.26%)
Current stock: BIIB